A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
Status:
Completed
Trial end date:
2020-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of fesoterodine at 4mg and 8mg doses
versus a placebo and oxybutynin 5mg bid versus placebo on cognitive abilities in older people
with overactive bladder and mild cognitive impairment.